The FDA said it will resume domestic inspections today, lifting the pause it put into place late last year as the omicron variant of COVID-19 was sweeping across the U.S.
The pause, which started Dec. 29, applied to certain inspection activities as the regulatory agency kept watch over the COVID-19 pandemic in order to make sure its employees and the firms it regulates were kept safe. The FDA continued to perform mission-critical inspections in the U.S. and abroad during the pause that was set to end Friday, it said.
